Amoéba Secures €4 Million from Vatel Capital in Capital Increase

Amoéba, a greentech company specializing in microbiological solutions, has announced a €4 million capital increase via private placement with Vatel Capital. The subscription price per share is set at €0.75, a 20% discount from the recent average share price. This strategic move aims to bolster Amoéba’s market position as it enters its commercialization phase. The funds will support the company's industrial ramp-up and marketing initiatives.

Additionally, Amoéba has negotiated a refinancing agreement with its major shareholder, Nice & Green, extending bond debt maturity to 2029 for enhanced financial agility. This agreement provides Amoéba with greater flexibility as it prepares for commercial growth, particularly in plant protection and cosmetics markets.